About Mitra Biotech
Mitra Biotech is a Healthcare company based in Woburn (United States) founded in 2010 by Mallik Sundaram. Mitra Biotech has raised $40.7 million across 3 funding rounds from investors including Tata Capital, Accel and RA Capital. The company has 1 employees. Its Indian entity Mitra Biotech Private Limited reported revenue of ₹1.36 Cr. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its competitors include C4 Therapeutics, Erasca and Revolution Medicines; 3 of its 3 listed competitors have raised funding.
Company details
Biotechnology company focused on advancing personalized cancer treatment through its clinically validated oncology drug efficacy platform, CANscript.
- Headquarters Woburn, United States
- Employees 1
- Founders Mallik Sundaram
- SectorsHealthcare
- Website mitrabiotech.com
- Social LinkedIn
- Legal Name Mitra Biotech Private Limited
- Date of Incorporation 18 Dec, 2009
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹1.36 Cr
FY 2016 · +30% YoY
- Indian entity net loss-₹4.67 Cr
FY 2016 · -343% margin
- Indian entity EBITDA-₹4.34 Cr
FY 2016 · -318% margin
- Total Equity Funding$40.7M (USD)
in 3 rounds
- Latest Funding Round$27.4M (USD), Series B
Aug 2016
- InvestorsTata Capital
& 7 more
- Employee Count1
Associated legal entities of Mitra Biotech
Mitra Biotech operates through Mitra Biotech Private Limited (dissolved (liquidated)). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2016) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mitra Biotech Private Limited CIN U73100KA2009PTC051875 | Dissolved (Liquidated) | 18 Dec 2009 | Bangalore, Karnataka | ₹1.4 Cr | 3 | View details |
Funding Insights of Mitra Biotech
Mitra Biotech has successfully raised a total of $40.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.4 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $40.7M
- Total Rounds 3
- Last Round Series B — $27.4M
- First Round $6.77M
(Apr 2010)
- Investors Count 8
All 3 funding rounds of Mitra Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2016 | $27.4M | Series B | – | Sequoia Capital, Sands Capital Ventures | |
| Oct 2013 | $6.53M | Series A | – | – | |
| Apr 2010 | $6.77M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in Mitra Biotech
Mitra Biotech has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Tata Capital, Accel and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Accel is recognized as a leading venture capital firm. | 1983 | accel.com | Palo Alto, United States | |
Venture capital fund backed by government financial institutions focused on early and growth stage startups | 1999 | kitven.in | Bengaluru, India | |
India focused early stage mivro VC firm | 2010 | indiainnovationfund.in | Bengaluru, India | |
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
Diversified non-banking financial services are provided by Tata Capital. | 2007 | tatacapital.com | Mumbai, India | |
Accel is recognized as a leading venture capital firm. | www.accel.com | Palo Alto, United States |
Investor details for Mitra Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Mitra Biotech Private Limited (Mitra Biotech)
Mitra Biotech Private Limited is the primary company behind Mitra Biotech. The board of Mitra Biotech Private Limited currently have 3 directors; the longest-serving is Mallikarjun Sundaram, appointed in 2009. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mallikarjun Sundaram DIN 01837321 | Director | 18 Dec 2009 | 16 yrs 10 mo | Mitra Biotech Private Limited |
| Pradip Kumar Majumder DIN 02985222 | Director | 31 Mar 2010 | 16 yrs 6 mo | Mitra Biotech Private Limited |
| Bindu Puthenpura Kanattu DIN 07592572 | Additional Director | 19 Dec 2016 | 9 yrs 10 mo | Mitra Biotech Private Limited |
People of Mitra Biotech
17 people are tracked at Mitra Biotech (6 in leadership, 11 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Mallik Sundaram | Co-Founder | Leadership |
Ragini Iyer | Associate Director Project Management | Leadership |
Satish Sankaran | Chief Scientific Officer | Leadership |
Mohit Malhotra | Chief Executive Officer | Leadership |
Christopher Davitt | Director, Partnerships And Commercial Strategy | Leadership |
Nandini Pal Basak | Director R&D India | Leadership |
Saikrishna S | Research Associate | Team |
Viral Patel | Research Scientist | Team |
Govindaraj Krishnan | Manager - Clinical Site | Team |
Dharanidharan M | Research Associate | Team |
Chandan B. | Research Associate | Team |
syam kumar | Senior Research Associate | Team |
Mouniss Murali Meenakshi | Senior Research Associate | Team |
Anupam Nath | Postdoctoral Research Fellow | Team |
Biswajit Das, PhD | Senior Scientist | Team |
Kumar Swamy | Sr. Manager | Team |
Oli Oliyarasi.M | Histopathology laboratory Manager | Team |
Complete people profiles for Mitra Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Mitra Biotech
Figures of Mitra Biotech Private Limited, the primary company behind Mitra Biotech, for FY 2016. Revenue was ₹1.36 Cr (+30% year on year). Net loss was -₹4.67 Cr (-343% margin). EBITDA was -₹4.34 Cr (-318% margin).
- ₹1.36 CrRevenue · FY 2016 · +30% YoY
- -₹4.67 CrNet loss · -343% margin
- -₹4.34 CrEBITDA · -318% margin
- ₹36.00 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Mitra Biotech Private Limited are on its company page.
Detailed financial statements for Mitra Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Mitra Biotech
3 dated milestones of Mitra Biotech across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Mitra Biotech is founded.
- Funding First funding round of $6.8M.
- Funding Latest funding round, Series B, of $27.4M.
Competitors of Mitra Biotech
Mitra Biotech has 3 listed competitors in our database, 3 of them funded. They include C4 Therapeutics, Erasca and Revolution Medicines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. |
Detailed competitors of Mitra Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mitra Biotech
Websites that share an audience with Mitra Biotech (mitrabiotech.com).
Websites whose visitors overlap most with Mitra Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aurusnet.com | 69% | View details |
Top companies in Oncology
3 companies that operate in the same segment as Mitra Biotech (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mitra Biotech
Mitra Biotech was founded in 2010.
Mitra Biotech is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Mitra Biotech is a funded company, having raised a total of $40.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6.77M, raised on Apr 2010.
Mitra Biotech has 1 employees.
The primary company behind Mitra Biotech, Mitra Biotech Private Limited, reported revenue of ₹1.36 Cr for FY 2016, up 30% year on year.
Biotechnology company focused on advancing personalized cancer treatment through its clinically validated oncology drug efficacy platform, CANscript.
Mitra Biotech's top competitors include C4 Therapeutics, Erasca and Revolution Medicines.
Mitra Biotech has 8 investors. Key investors include Tata Capital, Accel, RA Capital, KITVEN, and India Innovation Fund.
Mitra Biotech operates through Mitra Biotech Private Limited.
The legal entities of Mitra Biotech currently have 3 directors, including Pradip Kumar Majumder, Mallikarjun Sundaram, Bindu Puthenpura Kanattu.